Company Filing History:
Years Active: 2005
Title: Frédérique Bourriague-Seve: Innovator in Pharmaceutical Composition
Introduction: Frédérique Bourriague-Seve is a notable inventor based in Ferrieres les Verreries, France. With a focus on pharmaceutical innovations, he holds a patent that contributes to advances in drug formulation and treatment methods.
Latest Patents: Bourriague-Seve's most prominent patent is for a pharmaceutical composition for parenteral administration. This invention features dronedarone or its pharmaceutically acceptable salts as the active ingredient. The composition is enhanced by a physiologically acceptable buffer solution that maintains a pH level between 3 and 5, along with a water-soluble β-cyclodextrin derivative. This innovative combination aims to improve the efficacy and safety of dronedarone in medical therapies.
Career Highlights: Bourriague-Seve works at Sanofi-Aventis, a leading global biopharmaceutical company known for its commitment to innovation in healthcare. His role within the organization involves developing advanced pharmaceutical solutions tailored to patient needs and improving treatment outcomes.
Collaborations: In his pursuit of innovation, Bourriague-Seve collaborates with talented professionals such as Thierry Breul. Together, they contribute to the research and development of novel drug formulations, seeking to enhance therapeutic options available to patients.
Conclusion: Frédérique Bourriague-Seve's contributions to pharmaceutical science through his patented work signify an important step forward in the treatment landscape. His ongoing collaborations and commitment to innovation at Sanofi-Aventis reflect his dedication to improving healthcare outcomes.